Shepherd Kaplan Krochuk’s Novartis NVS Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,160	Closed	-$809K	–	244
2018 Q1	$809K	Buy	+11,160	New	+$850K	0.49%	58

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Shepherd Kaplan Krochuk's NVS Position: Q3 2015 in Review

Shepherd Kaplan Krochuk sold out of Novartis (NVS) in Q3 2015, closing a stake of 2,678 shares — an estimated $236K sold.

Shepherd Kaplan Krochuk first reported a position in NVS in Q2 2013 and held it in 9 quarters. The position peaked at $335K in Q3 2014. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

Shepherd Kaplan Krochuk reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 2,678 Novartis shares in Q3 2015, an estimated $236K.
Shepherd Kaplan Krochuk first reported a position in Novartis in Q2 2013 and held it in 9 quarters.
Shepherd Kaplan Krochuk's Novartis position peaked at $335K in Q3 2014.
926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q3 2015, filed 16 Nov 2015.